Issue of Share Options

RNS Number : 4947Z

Integumen PLC

18 September 2020

 

AIM share code: SKIN

18 September 2020

Integumen PLC

("Integumen" or "Company")

Issue of share options

Integumen plc announces that it has adopted a group share option scheme on 18 September 2020 under which Company employees will be eligible for awards.  The share option scheme includes an EMI scheme for UK employees and a Share Options Scheme for Irish employees, all subject to performance criteria.

The Company has granted share options over a total of 1,762,220 ordinary shares ("Shares") of £0.001 per share under the above schemes. Junior staff have been granted options with shorter vesting date and lower exercise price to reward, retain and recognise their contribution to date and their importance to the Company going forward. The EMI share options will lapse on 18 September 2030 and the Irish Share Options will lapse on 17 September 2027. No share options have been granted to PDMRs.

Gerard Brandon CEO Integumen plc commented:

"This share option program   will reward the innovation that has been delivered by all team associates, across the Integumen Group, and put in place, motivation for our most valuable assets to continue to deliver shareholder value over the next 3 years."

Number of options	Exercise price per Share	Vesting dates	Scheme under which options granted
310,320	£0.001	31/12/20 : 30% 31/3/21 : 35% 30/6/21 :35%	UK EMI Scheme
492,970	£0.355	1/1/21 : 30% 1/1/22 : 35% 1/1/23 :35%	UK EMI Scheme
42,250	£0.001	31/12/20 : 30% 31/3/21 : 35% 30/6/21 :35%	Ireland Share Option Scheme
916,680	£0.30	1/1/21 : 30% 1/1/22 : 35% 1/1/23 :35%	Ireland Share Option Scheme

Integumen plc	Gerard Brandon, CEO	[phone]
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Andrew Emmott	[phone]
Turner Pope Investments (TPI) Limited (Broker)	Andy Thacker/Zoe Alexander	[phone]

About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

END

 

 

IOEQVLFFBKLLBBL